STERIS to Acquire Xodus Medical

Xenetic Biosciences to Acquire Santersus AG

September 16, 2026

Medical Devices

Xenetic Biosciences entered into a definitive share exchange agreement to acquire all outstanding shares of Santersus AG in an all-stock transaction, subject to Xenetic stockholder approval and other customary closing conditions. The combination is intended to unite Santersus’ NucleoCapture blood-purification platform with Xenetic’s DNase technology and advance a broader pipeline targeting neutrophil extracellular traps across critical care, autoimmune disease, transplantation, and oncology.

STERIS Acquires Cantel Medical Corp.

January 12, 2021

Medical Devices

STERIS plc agreed to acquire Cantel Medical Corp. in a cash-and-stock transaction valuing Cantel at approximately $3.6 billion equity ($4.6 billion enterprise), paying $84.66 per Cantel share. The deal expands STERIS’s infection‑prevention and endoscopy capabilities and extends the company into dental customers, with expected pre‑tax cost synergies of ~$110 million by year four and accretion to adjusted EPS in year one.

STERIS Acquires Key Surgical from Water Street

November 18, 2020

Healthcare Services

STERIS plc signed a definitive agreement to acquire Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC, and later completed the sale. Under Water Street’s nearly four-year partnership, Key Surgical expanded globally across consumable sterile processing, operating room, and endoscopy product offerings.

Johnson & Johnson (Ethicon) Acquires Auris Health

April 1, 2019

Medical Devices

Johnson & Johnson, through its surgical devices unit Ethicon, completed the acquisition of Auris Health, Inc. for approximately $3.4 billion in cash with up to $2.35 billion in contingent payments. The deal brings Auris' Monarch robotic bronchoscopy platform and related digital surgery capabilities into J&J's medical devices portfolio to accelerate capability expansion in digital and robotic surgery, particularly for lung cancer diagnosis and intervention.

Cirtec Medical Acquires Stellar Technologies, Inc.

August 1, 2016

Medical Devices

Cirtec Medical, a portfolio company of Century Park Capital Partners, has acquired Stellar Technologies, Inc., a Brooklyn Park, Minnesota-based precision machining and medical component manufacturer. The acquisition expands Cirtec's manufacturing capabilities—particularly in neuromodulation lead wire assemblies, electro-mechanical devices and delivery systems—and establishes a presence in Minnesota's "Medical Alley."

Boston Scientific Acquires Xlumena

April 1, 2015

Medical Devices

Boston Scientific agreed to acquire Mountain View–based medical device company Xlumena, gaining the AXIOS and HOT AXIOS stent and delivery systems. The deal includes $62.5 million upfront, $12.5 million contingent on FDA clearance of HOT AXIOS and additional sales-based milestones, and is intended to expand Boston Scientific's endoscopy and EUS therapeutic capabilities and accelerate global commercialization of the AXIOS platform.